Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393

Lancet

Volumn 347, Issue 9002, 1996, Pages 635-639

  Eriksson, Bengt I ^a,c   Ekman, Steffan ^b   Kälebo, Peter ^a   Zachrisson, Bengt ^a   Bach, Doris ^b   Close, Philippe ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CIBA GEIGY LTD   (Switzerland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DESULFATOHIRUDIN; HEPARIN; LEPIRUDIN; THROMBIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORTHOPEDIC SURGERY; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

EID: 0029915374     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91200-3     Document Type: Article

References (20)

1. Eriksson BI, Kälebo P, Anthmyr BA, Wadenvik H, Tengborn L, Risberg B. Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. Comparison of a low molecular weight heparin and unfractionated heparin. J Bone Joint Surg 1991; 73A: 479-89.
2. Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-76.
3. Markwardt F, Hauptmann J, Nowak G, Walsmann P. Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb Haemost 1982; 47: 226-29.
4. Talbot MD, Ambler J, Butler KD, et al. Recominant desulphatohirudin (CGP 39393): comparative studies with standard and low molecular weight heparin. Int Soc Appl Cardiovasc Biol 1990; 1: 131-46.
5. Hauptmann J, Bruggener E, Markwardt F. Effect of heparin, hirudin and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats. Haemostasis 1987; 17: 321-28.
6. Kaiser B, Markwardt F. Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors. Thromb Res 1986; 43: 613-20.
7. Eriksson BI, Kälebo P, Ekman S, Lindbratt S, Kerry R, Close P. Direct thrombin inhibition wih rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement. Thromb Haemast 1994; 72: 227-31.
8. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-44.
9. Zachrisson BE, Jansen H. Phlebographic signs of fresh postoperative venous thrombosis in the lower extremity. Acta Radiol Diagn 1973; 14: 81-96.
10. Kälebo P, Anthmyr BA, Eriksson BI, Zachrisson BE. Phlebographic findings of venous thrombosis after total hip replacement. Acta Radiol 1990; 31: 259-63.
11. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983; 98: 891-99.
12. Biello DR, Mattar AG, McKnight RC, Siegel BA. Ventilation-perfusion studies in suspected pulmonary embolism. AJR 1979; 133: 1033-37.
13. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statistics 1979; 6: 65-70.
14. Casagrande JT, Pike MC, Smith PG. An improved approximative formula for calculating sample sizes for comparing two binominal distributions. Biometrics 1978; 34: 483-86.
15. Planes A, Vochelle N, Mazas F, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-10.
16. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low-molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-56.
17. Bergqvist D. Incidence of pulmonary embolism, pp 24-30. In: postoperative thromboembolism. Frequency, etiology, prophylaxis. Berlin, Heidelberg, New York: Springer-Verlag, 1983.
18. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162-73.
19. Havig Ö. Deep vein thrombosis and pulmonary embolism. An autopsy study with multiple regression analysis of possible risk factors. Acta Chir Scand 1977; 478 (suppl): 1-120.
20. Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep vein thrombosis? Ann Intern Med 1981; 94: 439-44.